Supporting Effect of Dronabinol on Behavioral Therapy in Fibromyalgia and Chronic Back Pain
CompletedPhase 2NCT00176163
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
It is known, that a so called "pain memory" usually evolves in chronic pain syndromes which both aggravates the disorder and modifies the patients pain perception. Thus, the principal object of pain therapy is to "delete" this dysfunctional pain memory. The combination of medication, physiotherapy and psychological therapy seems to be the most effective treatment. This study investigates the effect of a concomitant Dronabinol medication (Cannabinoid) on the effectiveness of behavioral therapy. It is hypothesized that the combination of behavioral therapy and Dronabinol will be most effective in deleting the pain memory.
Study details
- Official title
- Supporting Effect of Dronabinol on Behavioral Therapy in Fibromyalgia and Chronic Back Pain
- Conditions
- Interventions
- Behavioral: Operant behavioral treatment
- Drug: THC
- Sponsor
- Heidelberg University
- Collaborators
- Central Institute of Mental Health, Mannheim; University of Mannheim; Academic City Hospital, Germany; BG Trauma Center Ludwigshafen
- Start date
- 2005-08
- Sex
- All
- Age range
- from 18 Years to 70 Years
- Results posted
- No results posted in this snapshot
- Total sites listed
- 0
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Diagnosis of Fibromyalgia meeting ACR-criteria * Diagnosis of chronic back pain * Pain duration exceeding 3 months * Age between 18 and 70 years * The patient has been informed about the study, understood the information and signed the informed consent form Exclusion Criteria: * Tumors, fractures and heavy osteoporosis * Secondary back pain at arthrosis or degenerative scoliosis * Radicular back pain * Other pain syndrome is main problem * Opiate medication \> 60mg morphine per diem * Addiction (drugs, alcohol, medicaments) * Cardiac insufficiency \> NYHA II * Exercise induced dyspnea, Angina pectoris A detailed version of exclusion criteria: see study protocol
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT00176163